19例聚丙烯网片盆底重建术后阴道网片暴露相关因素分析被引量：2

导出

摘要目的：评价19例聚丙烯网片盆底重建术后（3~8年）阴道网片暴露情况及其危险因素分析。方法：对116例经盆腔脏器脱垂评分（pelvic organ prolapse quantitation,POP-Q）诊断为Ⅱ度及以上的盆腔脏器脱垂患者,行经阴道网片（聚丙烯材料）盆底重建术,分为前盆底、后盆底、全盆底重建术。术后检查阴道内有无网片组织暴露,且分析网片暴露的危险因素。结果：116例患者中19例出现网片暴露（直径≥0.2 cm）,暴露率为16.4%（19/116）。网片暴露组与非暴露组相比,其年龄、体质指数（BMI）、产次、是否同时行阴式子宫切除术、被动吸烟、高血压、糖尿病等均无统计学差异（P〉0.05）;与手术方式（前、后、全盆底重建术）相关（P〈0.05）,以前盆底重建术网片暴露发生率最低,为12.7%（13/102）。结论：聚丙烯网片盆底重建术其网片暴露的发生与年龄、BMI、产次、阴式子宫切除术、被动吸烟、高血压、糖尿病无关,其手术方式可能是唯一的危险因素。

作者陈湘陈艳琴王家俊龚健

机构地区南京医科大学附属无锡妇幼保健院妇泌科

出处《南京医科大学学报（自然科学版）》 CAS CSCD 北大核心 2014年第10期1433-1435,共3页 Journal of Nanjing Medical University(Natural Sciences)

关键词聚丙烯网片盆底重建术网片暴露

分类号 R713 [医药卫生—妇产科学]

引文网络
相关文献

参考文献9

1Alvarez J, Cvach K, Dwyer P. Complications in pelvic floor surgery [J]. Minerva Ginecol, 2013,65 ( 1 ) :53-67.
2Broeders IA,Schraffordt Koops SE. Placement of "mesh" should be carefully considered [J]. Ned Tijdsehr Ge- neeskd,2013,157(31 ) : A6598.
3Clemons JL,Weinstein M,Guess MK,et al. Impact of the 2011 FDA transvaginal mesh safety update on AUGS memmbers" use of synthetic mesh and biologic grafts in pelvic reconstructive surgery[J]. Female Pelvic Med Reconstr Surg,2013,19(4) : 191-198.
4Collinet P,Belot F,Debodinance P,et al. Transvaginal mesh technique for pelvic organ prolapse repair:mesh exposure management and risk factors [J]. Int Urogynecol J Pelvic Floor Dysfunct, 2006, 17 (4) : 315-320.
5Jacquetin B,Hinoul P,Gauld J,et al. Total transvaginal mesh (TVM)technique for treatment of pelvic organ pro- lapse : a 5-year prospective follow-up study [J]. Int Urogy- necol J,2013,24(10) : 1679-1686.
6张迎辉,鲁永鲜,刘昕,沈文洁,刘静霞.盆底重建术后阴道聚丙烯网片暴露对患者生命质量的影响[J].中华妇产科杂志,2012,47(8):608-611. 被引量：9
7Guillibert F,Chene G,Fanget C,et al. Risk factors of mesh exposure after transvaginal repair of genital pro- lapse[J]. Gynecol Obstet Fertil,2009,37(6) :470-5.
8Comu JN,Peyrat L,Haab F. Update in Management of Vaginal Mesh Erosion [J]. Curr Urol Rep,2013,14(5) : 471-475.
9Burks D,Rosenbury SB, Kennelly MJ,et al. Selective laser vaporization of polypropylene mesh used in treatment of female stress urinary incontinence and pelvic organ pro- lapse:preliminary studies using a red diode laser [J]. Lasers Surg Med,2012,44(4) :325-329.

二级参考文献21

1Mucowski SJ,Jurnalov C, Phelps JY. Use of vaginal mesh in the face of recent FDA warnings and litigation. Am J Obstet Gynecol, 2010,203:103. el-4.
2Haylen BT, Freeman RM, Swift SE, et al. An International Urogynecological Association ( IUGA )/International Continence Society ( ICS ) joint terminology and classification of the complications related directly to the insertion of prosthese (meshes,implants ,tapes) & grafts in female pelvic floor surgery. Int Urogynecol J,2011,22 : 3-15.
3Su TH, Lau HH, Huang WC, et al. Short term impact on female sexual function of pelvic floor reconstruction with the Prolift procedure. J Sex Med ,2009,6:3201-3207.
4Muffly T, Barber MD. Insertion and removal of vaginal mesh for pelvic organ prolapse. Clin Obstet Gynecol, 2010, 53:99-114.
5Clay6 A, Yahi H, Hammou JC, et al. Polypropylene as a reinforcement in pelvic surgery is not inert:comparative analysis of 100 explants. Int Urogyneeol J, 2010, 21:261-270.
6Milani AL, Withagen MI, Vierhout ME. Trocar-guidede total tension-free vaginal mesh repaire of post-hysterectomy vaginal vault prolapse. Int Urogynecol J, 2009, 20 : 1203-1211.
7Wetta LA,Gerten KA, Wheeler TL 2nd,et al. Synthetic graft use in vaginal prolapse surgexy:objective and subjective outcomes. Int Urogynecol J, 2009, 20:1307-1312.
8Culligan PJ, Littman PM, Salamon CG, et al. Evaluation of a transvaginal mesh delivery system for the correction of pelvic organ prolapse: subjective and objective findings at least 1 year after surgery. Am J Obstet Gynecol,2010,203:506. el 6.
9Mather C, Baessler K, Glazener CM, et al. Surgical management of pelvic organ prolapse in women:a short version Cochrane review. Neurourol Urodyn ,2008,27:3-12.
10Withagen MI, Vierhout ME, Hendriks JC, et al. Risks factors for exposure, pain, and dyspareunia "after tension-free vaginal mesh exposure. Obset Gyneco ,2011,118:629-636.